• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Vaxess Technologies raises $2M for its silk-based vaccine delivery through the skin

March 26, 2021 By Sean Whooley

Vaxess Technologies today filed an SEC Form D to confirm the sale of $2 million in debt, options, warrants or other rights to buy securities. According to the filing, three investors contributed to the new notice offering, which made its first sale on Monday, March 22, 2021, before reaching its total offering amount of $2 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Vaxess Technologies

Gyroscope Therapeutics raises $148M Series C

March 26, 2021 By Sean Whooley

Gyroscope Therapeutics

Gyroscope Therapeutics announced today that it raised $148 million (£107.8 million) in a Series C financing round. Forbion’s Growth Opportunities Fund led the round, while Sofinnova Investments, funds and accounts advised by T. Rowe Price, Tetragon Financial, Fosun Pharma, Cambridge Innovation Capital and Syncona, along with an undisclosed fund, contributed. In conjunction with the financing, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Optical/Ophthalmic Tagged With: Gyroscope Therapeutics

How 5G could affect medtech

March 26, 2021 By Sean Whooley

Cellphone using 5g

The latest standard of broadband technology continues to make waves in 2021. But what about medtech?   Cellphone using 5G (Imagy by Frederik Lipfert on Unsplash) Wireless tech companies such as Qualcomm are predicting download speeds as high as 10 gigabits per second as next-generation 5G cellular networks roll out worldwide. The open question in medtech is […]

Filed Under: Auto-injectors, Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: 5G, Dexcom, Medtronic, Philips

BD expands recall of ChloraPrep 3 ml applicator

March 25, 2021 By Sean Whooley

This is the logo of BD.

BD announced that it revised a previous press release from last week to expand a voluntary recall of its ChloraPrep 3 mL applicator. Franklin Lakes, N.J.-based BD initiated the recall for specified catalog numbers of the applicator device on June 23, 2020, due to possible fungal contamination under certain environmental conditions, according to a news […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance Tagged With: BD, Becton Dickinson

ACG launches NTone, TSafe range of capsules

March 25, 2021 By Sean Whooley

ACGcaps NTone and TSafe

ACG announced today that it launched its new ACGcaps NTone and ACGcaps TSafe range of capsules for the nutraceutical market. Mumbai, India-based ACG’s NTone portfolio includes naturally colored capsules with no e-number. THe colors used are safe and non-toxic and contain no artificial ingredients, while the product shelf life is unchanged compared to synthetic-colored capsules, […]

Filed Under: Featured, Pharmaceuticals Tagged With: ACG

J&J Vision wins Japanese approval for first drug-releasing contact lens

March 25, 2021 By Sean Whooley

Johnson & Johnson Vision Acuvue Theravision

Johnson & Johnson Vision announced that it received approval in Japan for its Acuvue Theravision lens with Ketotifen. The company touts the lens as the first and only vision-correcting contact lens that relieves allergic eye itch through drug delivery, according to a news release. Japan’s Ministry of Health, Labour and Welfare (MHLW) approved the lens, […]

Filed Under: Drug-Device Combinations, Featured, Optical/Ophthalmic, Regulatory/Compliance Tagged With: Johnson & Johnson

Eyenovia partners with Eversana to commercialize pupil dilation agent

March 23, 2021 By Sean Whooley

Eyenovia Eversana

Eyenovia (NSDQ:EYEN) announced today that it partnered with Eversana to help commercialize MydCombi if it earns U.S. approval. MydCombi is a fixed-combination mydriatic agent for potential use in comprehensive eye exams with a formulation for touchless fixed-combination microdosing in an effort to improve the patient experience. The FDA earlier this month accepted Eyenovia’s New Drug […]

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Featured, Optical/Ophthalmic Tagged With: Eversana, Eyenovia Inc.

Research indicates notable future growth in transdermal patch market

March 23, 2021 By Sean Whooley

adhesive microneedle coin-sized insulin patch UCLA diabetes

Research published today has highlighted potential growth down the line in the transdermal drug delivery patch space. Kuick Research published an analysis claiming that the U.S. transdermal patch drug market is revolving on account of two powerful “mega-trends.” Those trends — acceleration in the U.S. pharmaceutical market growth and the restructuring of the healthcare sector […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured Tagged With: Drug delivery

Fractyl enrolls first patient in Revita DMR treatment for Type 2 diabetes

March 22, 2021 By Sean Whooley

Fractyl

Fractyl Laboratories announced today that it enrolled the first patient in the trial for its Revita DMR Type 2 diabetes treatment. The Revita-T2Di trial will evaluate a single Revita DMR treatment to allow patients currently on insulin therapy but with inadequate glycemic control to achieve durable insulin-free glycemic control. The company will seek to use […]

Filed Under: Clinical Trials, Diabetes, Featured Tagged With: fractyllaboratories

BioCorp, Diabeloop partner on diabetes management tech development

March 22, 2021 By Sean Whooley

Biocorp Diabeloop

BioCorp and Diabeloop announced today that they are entering a cooperation agreement to develop new personalized diabetes treatments. Diabeloop develops automated insulin delivery (AID) systems, including a self-learning algorithm hosted in a handset and connected to a continuous glucose monitoring (CGM) system and an insulin pump. The platform analyzes glucose data, calculates the right dose […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: biocorp, Diabeloop

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Page 152
  • Interim pages omitted …
  • Page 173
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS